CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/22/2026
-
MarketBeat
9/8/2026
-
MarketBeat
9/8/2026
-
Insider Monkey
9/7/2026
-
Zacks Investment Research
9/4/2026
-
MarketBeat
9/1/2026
-
Globe Newswire
8/31/2026
-
Zacks Investment Research
8/20/2026
-
Nasdaq News: Markets
8/20/2026
-
Zacks Investment Research
8/20/2026
-
Fool.com Headlines
8/19/2026
-
Tickeron - Stocks
8/18/2026
-
MarketBeat
8/18/2026
-
Seeking Alpha - Healthcare
8/18/2026
-
SeekingAlpha
8/17/2026
-
The Cerbat Gem
8/17/2026
-
MarketBeat
8/17/2026
-
MarketBeat
8/14/2026
-
Simply Wall St
8/14/2026
-
Insider Monkey
8/14/2026
-
The Cerbat Gem
8/14/2026
-
MarketBeat
8/14/2026
-
The Cerbat Gem
8/14/2026
-
MarketBeat
8/14/2026
-
Zacks Investment Research
5/14/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
908 517 9500
Address
389 Interpace Pkwy
Suite 450
Parsippany, NJ 07054
Suite 450
Parsippany, NJ 07054
Country
Year Founded
Business Description
Sector
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product...
more